Takeda Pharmaceutical
TAK
$15.84
Share price
-0.56%
Change (1 day)
14.04%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total assets
Total assets on the balance sheet as of June 2023 : $102.17 B
According to Takeda Pharmaceutical's latest financial reports the company's total assets are $102.17 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Takeda Pharmaceutical - Total assets on balance sheet (from 2008 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-03-31 | $104.78 B | -2.97% |
| 2022-03-31 | $107.99 B | -7.74% |
| 2021-03-31 | $117.05 B | -1.36% |
| 2020-03-31 | $118.67 B | -5.05% |
| 2019-03-31 | $124.98 B | 223.56% |
| 2018-03-31 | $38.62 B | -0.88% |
| 2017-03-31 | $38.96 B | 14.51% |
| 2016-03-31 | $34.03 B | -4.93% |
| 2015-03-31 | $35.79 B | -19.39% |
| 2014-03-31 | $44.40 B | 5.85% |
| 2013-03-31 | $41.95 B | -2.8% |
| 2012-03-31 | $43.16 B | 28.81% |
| 2011-03-31 | $33.51 B | 11% |
| 2010-03-31 | $30.18 B | 8.25% |
| 2009-03-31 | $27.88 B | -2.27% |
| 2008-03-31 | $28.53 B | 9.37% |
| 2007-03-31 | $26.09 B | 0.99% |
| 2006-03-31 | $25.83 B | 8.74% |
| 2005-03-31 | $23.75 B | 6% |
| 2004-03-31 | $22.41 B | 28.44% |
| 2003-03-31 | $17.45 B | 18.38% |
| 2002-03-31 | $14.74 B | 6.82% |
| 2001-03-31 | $13.80 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $195.96 B | 91.80% | 🇺🇸 USA |
 Novartis NVS | $110.97 B | 8.62% | 🇨🇭 Switzerland |
 Pfizer PFE | $195.61 B | 91.45% | 🇺🇸 USA |
 Amgen AMGN | $90.26 B | -11.65% | 🇺🇸 USA |
 Sanofi SNY | $136.23 B | 33.34% | 🇫🇷 France |
 Merck MRK | $107.79 B | 5.50% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.00 B | -26.59% | 🇬🇧 UK |
 Seagen
SGEN | $3.49 B | -96.58% | 🇺🇸 USA |
 Dr. Reddy's RDY | $3.93 B | -96.15% | 🇮🇳 India |